Recombinant Human Myelin Oligodendrocyte Glycoprotein
Recombinant Human Myelin Oligodendrocyte Glycoprotein
Product Specifications
CAS Number
9000-83-3
Product Name Alternative
MOG
Gene Name
MOG
UniProt
Q16653
Cellular Locus
[Isoform 1]: Cell membrane , Multi-pass membrane protein , Multi-pass membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein , Single-pass type I membrane protein
Reactivity
Human
Target Antigen
Myelin-oligodendrocyte glycoprotein
Target
Myelin Oligodendrocyte Glycoprotein
Type
Protein
Applications
WB
Dilution
Reconstitute lyophilized MOG in sterile 10mM acetic acid to no less than 100ug/ml which can be further diluted in other aqueous solutions as needed.
Form
Lyophilized
Function
Mediates homophilic cell-cell adhesion (By similarity). Minor component of the myelin sheath. May be involved in completion and/or maintenance of the myelin sheath and in cell-cell communication. {PubMed:21880773}.
Storage Conditions
Although stable at room temperature for 3 weeks, the lyophilized product is best stored at or below -20°C. Upon reconstitution, product can be stored at 4°C for up to 1 week but is best stored at or below -20°C for longer periods of time. Addition of a carrier protein (such as 0.1% HSA or BSA) is recommended for long- term storage.
Specificity
Myelin Oligodendrocyte Glycoprotein
Formulation
Reconstitute lyophilized MOG in sterile 50mM acetic acid to no less than 100ug/ml which can be further diluted in other aqueous solutions as needed.
Target Background
Myelin Oligodendrocyte Glycoprotein (MOG) is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Given its localization, it is a prime target antigen of immune-mediated demyelination. MOG is involved in completion and maintenance of the myelin sheath and in cell-cell communication. MOG is differentially expressed in the dorsolateral prefrontal cortex and in the temporal lobe from patients with schizophrenia.
More Discoveries
Explore Other Products
Browse additional items from our catalog